Total Payments
$329,714
2024 Payments
$4,094
Companies
34
Transactions
202
Medicare Patients
4,522
Medicare Billing
$2.9M
Payment Breakdown by Category
Research$276,083 (83.7%)
Royalty/License$24,049 (7.3%)
Consulting$19,993 (6.1%)
Food & Beverage$6,149 (1.9%)
Other$2,352 (0.7%)
Travel$1,073 (0.3%)
Education$14.13 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $276,083 | 47 | 83.7% |
| Royalty or License | $24,049 | 1 | 7.3% |
| Consulting Fee | $19,993 | 14 | 6.1% |
| Food and Beverage | $6,149 | 132 | 1.9% |
| Current or prospective ownership or investment interest | $2,352 | 5 | 0.7% |
| Travel and Lodging | $1,073 | 2 | 0.3% |
| Education | $14.13 | 1 | 0.0% |
Payments by Type
Research
$276,083
39 transactions
General
$53,630
155 transactions
Ownership
$0
8 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech, Inc. | $276,136 | 42 | $0 (2021) |
| Alcon Research Ltd | $25,449 | 2 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $15,409 | 27 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $3,065 | 9 | $0 (2021) |
| Alimera Sciences, Inc. | $2,614 | 18 | $0 (2024) |
| US Retina LLC | $2,352 | 13 | $0 (2024) |
| GENZYME CORPORATION | $1,280 | 1 | $0 (2023) |
| Alcon Laboratories Inc | $700.00 | 1 | $0 (2017) |
| ABBVIE INC. | $482.08 | 18 | $0 (2024) |
| Genentech USA, Inc. | $249.29 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,094 | 24 | Regeneron Healthcare Solutions, Inc. ($3,648) |
| 2023 | $5,901 | 22 | Regeneron Healthcare Solutions, Inc. ($3,428) |
| 2022 | $4,102 | 25 | Regeneron Healthcare Solutions, Inc. ($1,661) |
| 2021 | $3,052 | 17 | Regeneron Healthcare Solutions, Inc. ($1,620) |
| 2020 | $30,942 | 19 | Genentech, Inc. ($26,566) |
| 2019 | $38,465 | 45 | Genentech, Inc. ($36,365) |
| 2018 | $182,940 | 29 | Genentech, Inc. ($154,379) |
| 2017 | $60,216 | 21 | Genentech, Inc. ($58,813) |
All Payment Transactions
202 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $27.14 | General |
| Category: EYE CARE | ||||||
| 11/07/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $26.29 | General |
| Category: EYE CARE | ||||||
| 10/28/2024 | EyePoint Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $27.45 | General |
| 10/23/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: EYE CARE | ||||||
| 10/10/2024 | Sandoz Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $30.35 | General |
| Category: Ophthalmology | ||||||
| 09/26/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $31.16 | General |
| Category: EYE CARE | ||||||
| 08/15/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $30.20 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/12/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Consulting Fee | Cash or cash equivalent | $1,674.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/12/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Ophthalmology | ||||||
| 06/05/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $30.09 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/22/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $28.05 | General |
| Category: EYE CARE | ||||||
| 05/02/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: EYE CARE | ||||||
| 04/25/2024 | Genentech USA, Inc. | Susvimo (Drug), Vabysmo | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/16/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $33.59 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/20/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 03/20/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 03/14/2024 | Sandoz Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: Ophthalmology | ||||||
| 03/08/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $27.99 | General |
| Category: EYE CARE | ||||||
| 03/01/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: Dry eyes | ||||||
| 02/15/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: Immunology and Ophthalmology | ||||||
| 02/07/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: Inflammation/Rare Disease | ||||||
| 01/26/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological), EYLEA | Consulting Fee | Cash or cash equivalent | $1,880.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/25/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: EYE CARE | ||||||
| 2024 | US Retina LLC | — | — | — | $0.00 | Ownership |
| 12/20/2023 | AbbVie Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: EYE CARE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| LUCENTIS FSV4 LAD AMD LADDER | Genentech, Inc. | $276,083 | 39 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 612 | 1,432 | $514,800 | $238,577 |
| 2022 | 14 | 1,255 | 3,964 | $1.7M | $769,402 |
| 2021 | 16 | 1,312 | 4,122 | $1.9M | $943,140 |
| 2020 | 15 | 1,343 | 4,126 | $1.8M | $902,066 |
Total Patients
4,522
Total Services
13,644
Medicare Billing
$2.9M
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 26 | 264 | $330,000 | $171,732 | 52.0% |
| 67028 | Injection of drug into eye | Office | 2023 | 62 | 258 | $62,775 | $23,365 | 37.2% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 141 | 181 | $32,580 | $15,723 | 48.3% |
| 92134 | Imaging of retina | Office | 2023 | 168 | 410 | $30,750 | $11,360 | 36.9% |
| J3590 | Unclassified biologics | Office | 2023 | 28 | 105 | $23,550 | $7,141 | 30.3% |
| 92250 | Photography of the retina | Office | 2023 | 113 | 134 | $20,100 | $3,532 | 17.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $6,615 | $3,188 | 48.2% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 36 | 42 | $6,300 | $1,401 | 22.2% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 11 | 11 | $2,130 | $1,135 | 53.3% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 65 | 676 | $845,000 | $484,016 | 57.3% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 20 | 565 | $272,600 | $124,137 | 45.5% |
| 67028 | Injection of drug into eye | Office | 2022 | 168 | 695 | $344,240 | $64,587 | 18.8% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 214 | 302 | $55,035 | $25,618 | 46.5% |
| 92134 | Imaging of retina | Office | 2022 | 332 | 915 | $76,875 | $25,466 | 33.1% |
| J3590 | Unclassified biologics | Office | 2022 | 82 | 369 | $73,800 | $19,792 | 26.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 75 | 89 | $19,160 | $8,154 | 42.6% |
| 92250 | Photography of the retina | Office | 2022 | 156 | 189 | $27,125 | $4,876 | 18.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 22 | 22 | $6,930 | $3,825 | 55.2% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 26 | 28 | $6,310 | $2,555 | 40.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $4,690 | $2,024 | 43.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 28 | $3,625 | $1,619 | 44.7% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2022 | 37 | 45 | $6,750 | $1,494 | 22.1% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 15 | 22 | $2,575 | $1,239 | 48.1% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2021 | 76 | 922 | $1.2M | $680,097 | 59.0% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2021 | 12 | 340 | $162,650 | $86,482 | 53.2% |
About Dr. Thomas Aaberg, MD
Dr. Thomas Aaberg, MD is a Ophthalmology healthcare provider based in Grand Rapids, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1194753186.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Aaberg, MD has received a total of $329,714 in payments from pharmaceutical and medical device companies, with $4,094 received in 2024. These payments were reported across 202 transactions from 34 companies. The most common payment nature is "" ($276,083).
As a Medicare-enrolled provider, Aaberg has provided services to 4,522 Medicare beneficiaries, totaling 13,644 services with total Medicare billing of $2.9M. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Uveitis and Ocular Inflammatory Disease, Retina Specialist
- Location Grand Rapids, MI
- Active Since 06/29/2006
- Last Updated 01/26/2021
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1194753186
Products in Payments
- Lucentis (Biological) $232,616
- Non-Covered Product (Drug) $43,746
- NGENUITY (Device) $24,049
- EYLEA (Biological) $12,379
- STELLARIS (Device) $2,948
- ILUVIEN (Drug) $2,416
- EYLEA HD (Biological) $1,920
- Luxor (Device) $1,547
- EYLEA AFLIBERCEPT INJECTION (Biological) $1,228
- Constellation (Device) $743.44
- OZURDEX (Drug) $510.47
- Cimerli (Biological) $221.14
- YUTIQ (Drug) $164.16
- TEPEZZA (Drug) $146.69
- STELLARIS PC (Device) $112.01
- Iluvien (Drug) $80.14
- DUREZOL (Drug) $75.80
- VISUDYNE (Drug) $70.55
- BEOVU (Drug) $68.82
- ACTHAR (Biological) $55.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Grand Rapids
Scott Westhouse, D.o, D.O
Ophthalmology — Payments: $96,762
Ophthalmology $96,762
Dr. Edward Korot, M.d, M.D
Ophthalmology — Payments: $43,512
Ophthalmology $43,512
Roman Krivochenitser, M.d, M.D
Ophthalmology — Payments: $21,287
Ophthalmology $21,287
Dr. Joseph Boss, M.d, M.D
Ophthalmology — Payments: $21,268
Ophthalmology $21,268
Dr. Marcus Muallem, Md, MD
Ophthalmology — Payments: $14,992
Ophthalmology $14,992
Dr. Liliya Sutherland, D.o, D.O
Ophthalmology — Payments: $13,103
Ophthalmology $13,103